Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Pediatric Therapeutics Office Could Fall Under ORM Purview

This article was originally published in The Tan Sheet

Executive Summary

FDA's Office of Pediatric Therapeutics would be located within the Office of Review Management under proposed organizational changes at the agency.
Advertisement

Related Content

CDER Deputy Director Galson To Head Drug Center For Several Months
CDER Deputy Director Galson To Head Drug Center For Several Months
CDER Deputy Director Galson To Head Drug Center For Several Months
FDA restructuring
FDA restructuring
FDA restructuring
Pediatric Labeling Negotiations Limited To Six Months In Reauthorization Bill
Pediatric Labeling Negotiations Limited To Six Months In Reauthorization Bill

Topics

Advertisement
UsernamePublicRestriction

Register

PS092788

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel